Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer. (Q48907572)

16 February 2018

title

Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer. (English)

1 reference

16 February 2018

0 references

1 reference

Hans Geinitz

1

1 reference

16 February 2018

Reinhard Thamm

2

1 reference

16 February 2018

Christian Scholz

3

1 reference

16 February 2018

Christine Heinrich

4

1 reference

16 February 2018

Nina Prause

5

1 reference

16 February 2018

Simone Kerndl

6

1 reference

16 February 2018

Monika Keller

7

1 reference

16 February 2018

Raymonde Busch

8

1 reference

16 February 2018

Michael Molls

9

1 reference

16 February 2018

Frank B Zimmermann

10

1 reference

16 February 2018

publication date

28 December 2009

1 reference

16 February 2018

Strahlentherapie und Onkologie

published in

1 reference

16 February 2018

volume

186

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

page(s)

46-52

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/s00066-009-2023-7

exact match

0 references

cites work

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis. A prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

A phase II randomized study of topical intrarectal administration of amifostine for the prevention of acute radiation-induced rectal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

The clinical significance of quality of life assessments in oncology: a summary for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

RTOG's first quality of life study--RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

Fatigue during breast radiotherapy and its relationship to biological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2023-7

3D conformal radiation therapy for prostate cancer in elderly patients

21 January 2018

1 reference

12 December 2020

Fatigue in patients with cancer. Analysis and assessment

1 reference

12 December 2020

Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer

1 reference

12 December 2020

Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy)

1 reference

12 December 2020

Dose-Response Relations for Anal Sphincter Regarding Fecal Leakage and Blood or Phlegm in Stools after Radiotherapy for Prostate Cancer

1 reference

12 December 2020

Single-institution results of primary external-beam radiation for the treatment of t1-t3 prostate cancer

1 reference

12 December 2020

Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial

1 reference

12 December 2020

The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer

1 reference

12 December 2020

Quality of life changes during conformal radiation therapy for prostate carcinoma

1 reference

12 December 2020

Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer

1 reference

12 December 2020

Prospective evaluation of fatigue during a course of curative radiotherapy for localised prostate cancer

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00066-009-2023-7

Identifiers

DOI

1 reference

16 February 2018

PubMed ID

20082188

1 reference

16 February 2018